HCPCS Level II
J9321
Injection, epcoritamab-bysp, 0.16 mg
Codes near J9321
These sit next to J9321 in the CMS Level II file. All J codes
- J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
- J9317Injection, sacituzumab govitecan-hziy, 2.5 mg
- J9318Injection, romidepsin, non-lyophilized, 0.1 mg
- J9319Injection, romidepsin, lyophilized, 0.1 mg
- J9320Injection, streptozocin, 1 gram
- J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg
- J9323Injection, pemetrexed ditromethamine, 10 mg
- J9324Injection, pemetrexed (pemrydi rtu), 10 mg
- J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9326Injection, telisotuzumab vedotin-tllv, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 82705-0002-01 | Epkinly | Genmab US, Inc. | 25 |
| 82705-0010-01 | Epkinly | Genmab US, Inc. | 300 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.